Cholesteatoma Severity Determines the Risk of Recurrent Paediatric Cholesteatoma More Than the Surgical Approach
Journal of Clinical Medicine · 01.02.2024 · 13 (3) · 836
DOI: 10.3390/jcm13030836 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 01.02.2024. Verfasst von Adrian L James. Beteiligte Einrichtung: Department of Otolaryngology-Head & Neck Surgery, Hospital for Sick Children, Toronto, ON M5G 1X8, Canada. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To evaluate factors that influence the rate of cholesteatoma recurrence (growth of new retraction cholesteatoma) in children.
Methods
Review of children with primary acquired or congenital cholesteatoma. Severity was classified by extent and EAONO-JOS stage, and surgery by SAMEO-ATO. Primary outcome measure was 5-year recurrence rate using Kaplan–Meier or Cox regression analysis.
Results
Median age was 10.7 years for 408 cholesteatomas from which 64 recurred. Median follow up was 4.6 years (0–13.5 years) with 5-year recurrence rate of 16% and 10-year of 29%. Congenital cholesteatoma (n = 51) had 15% 5-year recurrence. Of 216 pars tensa cholesteatomas, 5-year recurrence was similar at 14%, whereas recurrence from 100 pars flaccida cholesteatomas was more common at 23% (log-rank, p = 0.001). Sub-division of EAONO-JOS Stage 2 showed more recurrence in those with than without mastoid cholesteatoma (22.1% versus 10%), with more in Stage 3 (31.9%; p = 0.0003). Surgery without mastoidectomy, including totally endoscopic ear surgery, had 11% 5-year recurrence. Canal wall-up tympanomastoidectomy (CWU) and canal wall-down/mastoid obliteration both had 23% 5-year recurrence. Multivariate analysis showed increased recurrence for EAONO-JOS Stage 3 (HR 5.1; CI: 1.4–18.5) at risk syndromes (HR 2.88; 1.1–7.5) and age < 7 years (HR 1.9; 1.1–3.3), but not for surgical category or other factors.
Conclusion
Young age and more extensive cholesteatoma increase the risk of recurrent cholesteatoma in children. When controlling for these factors, surgical approach does not have a significant effect on this outcome. Other objectives, such as lower post-operative morbidity and better hearing outcome, may prove to be more appropriate parameters for selecting optimal surgical approach in children.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head & Neck Surgery, Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.
- Division of Otology & Neurotology, Department of Otolaryngology-Head & Neck Surgery, University of Toronto, Toronto, ON M5S 1A8, Canada.
ORCID-Profile: Adrian L James
Zitieren
APA
James, A. L. (2024). Cholesteatoma Severity Determines the Risk of Recurrent Paediatric Cholesteatoma More Than the Surgical Approach. Journal of Clinical Medicine, 13(3), 836. https://doi.org/10.3390/jcm13030836
Vancouver
James AL. Cholesteatoma Severity Determines the Risk of Recurrent Paediatric Cholesteatoma More Than the Surgical Approach. Journal of Clinical Medicine. 2024;13(3):836. doi:10.3390/jcm13030836
BibTeX
@article{James2024,
author = {James, Adrian L},
title = {Cholesteatoma Severity Determines the Risk of Recurrent Paediatric Cholesteatoma More Than the Surgical Approach},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {3},
pages = {836},
doi = {10.3390/jcm13030836}
}
EUVIMED